Terumo Neuro, a global leader in neurovascular innovation and a wholly-owned subsidiary of Terumo Corporation, proudly celebrates the 15th anniversary of the revolutionary WEB™ Aneurysm Embolization System. Since its introduction, the WEB device has transformed the treatment of wide-neck bifurcation aneurysms, providing physicians and patients with a clinically proven, one-device solution – One and Done – proven to be simple, safe and durable, for ruptured aneurysms* and demonstrated innovation. The marketing of the WEB device was launched on the site in October 2010 after obtaining the CE mark (European Conformity) in Europe. The first implant was made by Professor Joachim Klisch in Germany, ushering in a new era in the treatment of aneurysms.

The WEB device has proven clinical data, supported by seven global Good Clinical Practice (GCP) studies and more than 200 peer-reviewed publications. Over the past 15 years, this revolutionary technology has changed the paradigm of aneurysm treatment, providing a safe and effective alternative to traditional methods.

Carsten Schroeder, President and CEO of Terumo Neuro, commented on this important milestone: "The WEB device has introduced a new standard in the treatment of aneurysms and has been instrumental in our mission to change the game in neurovascular care. After 15 years of proven clinical success, WEB continues to advance patient outcomes, reducing the need for multiple devices and lengthy procedures. As we celebrate this achievement, we remain committed to innovating alongside the world's leading physicians to shape the future of neurovascular care.